
Roche's Tina-quant Lp(a) RxDx assay, a blood test that measures lipoprotein(a) levels, has received breakthrough device designation from the FDA to identify adults with elevated Lp(a) who may benefit from emerging lipid-lowering therapies.


coremsg

The Tina-quant Lp(a) RxDx assay identifies adults with elevated Lp(a) levels who might benefit from innovative lipid-lowering therapies currently in development.

Roche Blood Test for Lp(a) Designated Breakthrough Device

roche-s-breakthrough-blood-test-for-measuring-lipoprotein-a-levels-to-assess-cardiovascular-risk


Roche's Breakthrough Blood Test for Measuring Lipoprotein(a) Levels to Assess Cardiovascular Risk
